INVION LIMITED

 

Area: Country Pavilion

Booth No: L732

Website: https://www.inviongroup.com

 

Exhibitor Profile

 

Invion (ASX: IVX) is a clinical-stage Australian life sciences company developing its Next-Generation Photodynamic Therapy (NGPDT) for the treatment of a range of cancers. The technology is a precision cancer targeting therapy that is powered by light.

It uses non-toxic photosensitisers activated by a specific wavelength of light to selectively kill cancer cells and promote an anti-cancer immune response.

Highlights of our platform technology for treating cancers include:
•Selectively targets and kills cancer cells by taking advantage of the Warburg effect
•Activation of immune response including when combined with immunotherapies (ICC) increased response rates from 12% to 80%
•Undertaking clinical trials across multiple cancers and results so far show our treatments to be both safe and demonstrate efficacy signals (awarded Orphan Drug Designation by FDA for anal cancers)
•Industry partners have already recognised the potential of our technology and are providing non-dilutive funding for a number of our programs
•Expanding therapeutic targets to companion animal cancers,

 

 

 

back